Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-24 @ 3:01 PM
NCT ID:
NCT00447759
Eligibility Criteria:
Inclusion Criteria:
* Subjects 60 years or over Male \& Female
* Chronic NSAIDs use for 90 days or more in a 12 month period
* Subjects who have a licensed indication for chronic non-selective NSAID or Celecoxib.
* Eligible for treatment with either Celecoxib or alternative traditional non-selective NSAID.
* Subjects who are willing to consent to their paper and electronic medical records and prescribing data to be accessed.
* Subjects who are willing to be contacted and interviewed by trial investigators.
Exclusion Criteria:
* Established cardiovascular disease including ischaemic heart disease, Myocardial Infarction, angina or acute coronary syndrome, cerebrovascular disease or cerebrovascular accident or transient ischaemic attack, established peripheral vascular disease and moderate to severe heart failure.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT00447759
Study Brief:
Protocol Section:
NCT00447759